PANOBINOSTAT LACTATE
| Brand name | FARYDAK |
|---|---|
| Active ingredient | PANOBINOSTAT LACTATE |
| Strength | EQ 20MG BASE |
| Dosage form | CAPSULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | February 2015 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 8883842 | June 2028 | use U-1669 |
| 7989494 | January 2028 | substance, product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.